Zevra Therapeutics
ZVRA
ZVRA
83 hedge funds and large institutions have $45.4M invested in Zevra Therapeutics in 2022 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more call options, than puts
Call options by funds: $6.61M | Put options by funds: $6.54M
28% less capital invested
Capital invested by funds: $63.1M → $45.4M (-$17.7M)
Holders
83
Holding in Top 10
–
Calls
$6.61M
Puts
$6.54M
Top Buyers
| 1 | +$1.61M | |
| 2 | +$1.28M | |
| 3 | +$1.2M | |
| 4 |
Renaissance Technologies
New York
|
+$816K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$753K |
Top Sellers
| 1 | -$327K | |
| 2 | -$295K | |
| 3 | -$220K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$212K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$207K |